154 related articles for article (PubMed ID: 37394607)
1. Isosteric Replacement of Ester Linkage of Lysophospholipids with Heteroaromatic Rings Retains Potency and Subtype Selectivity.
Ikubo M; Uwamizu A; Chen L; Nakamura S; Sayama M; Kawana H; Otani Y; Kano K; Inoue A; Aoki J; Ohwada T
Chem Pharm Bull (Tokyo); 2023; 71(7):584-615. PubMed ID: 37394607
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of lysophosphatidylserine analogs as agonists of G-protein-coupled receptors GPR34, P2Y10, and GPR174.
Ikubo M; Inoue A; Nakamura S; Jung S; Sayama M; Otani Y; Uwamizu A; Suzuki K; Kishi T; Shuto A; Ishiguro J; Okudaira M; Kano K; Makide K; Aoki J; Ohwada T
J Med Chem; 2015 May; 58(10):4204-19. PubMed ID: 25970039
[TBL] [Abstract][Full Text] [Related]
3. GPR34 as a lysophosphatidylserine receptor.
Makide K; Aoki J
J Biochem; 2013 Apr; 153(4):327-9. PubMed ID: 23389307
[TBL] [Abstract][Full Text] [Related]
4. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position.
Kitamura H; Makide K; Shuto A; Ikubo M; Inoue A; Suzuki K; Sato Y; Nakamura S; Otani Y; Ohwada T; Aoki J
J Biochem; 2012 May; 151(5):511-8. PubMed ID: 22343749
[TBL] [Abstract][Full Text] [Related]
5. Conformational Constraint of the Glycerol Moiety of Lysophosphatidylserine Affords Compounds with Receptor Subtype Selectivity.
Jung S; Inoue A; Nakamura S; Kishi T; Uwamizu A; Sayama M; Ikubo M; Otani Y; Kano K; Makide K; Aoki J; Ohwada T
J Med Chem; 2016 Apr; 59(8):3750-76. PubMed ID: 27077565
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for lysophosphatidylserine recognition by GPR34.
Izume T; Kawahara R; Uwamizu A; Chen L; Yaginuma S; Omi J; Kawana H; Hou F; Sano FK; Tanaka T; Kobayashi K; Okamoto HH; Kise Y; Ohwada T; Aoki J; Shihoya W; Nureki O
Nat Commun; 2024 Feb; 15(1):902. PubMed ID: 38326347
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylserine analogues differentially activate three LysoPS receptors.
Uwamizu A; Inoue A; Suzuki K; Okudaira M; Shuto A; Shinjo Y; Ishiguro J; Makide K; Ikubo M; Nakamura S; Jung S; Sayama M; Otani Y; Ohwada T; Aoki J
J Biochem; 2015 Mar; 157(3):151-60. PubMed ID: 25320102
[TBL] [Abstract][Full Text] [Related]
8. Non-naturally Occurring Regio Isomer of Lysophosphatidylserine Exhibits Potent Agonistic Activity toward G Protein-Coupled Receptors.
Nakamura S; Sayama M; Uwamizu A; Jung S; Ikubo M; Otani Y; Kano K; Omi J; Inoue A; Aoki J; Ohwada T
J Med Chem; 2020 Sep; 63(17):9990-10029. PubMed ID: 32787112
[TBL] [Abstract][Full Text] [Related]
9. Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine.
Sayama M; Uwamizu A; Ikubo M; Chen L; Yan G; Otani Y; Inoue A; Aoki J; Ohwada T
J Med Chem; 2021 Jul; 64(14):10059-10101. PubMed ID: 34233115
[TBL] [Abstract][Full Text] [Related]
10. Novel lysophosphoplipid receptors: their structure and function.
Makide K; Uwamizu A; Shinjo Y; Ishiguro J; Okutani M; Inoue A; Aoki J
J Lipid Res; 2014 Oct; 55(10):1986-95. PubMed ID: 24891334
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for ligand recognition and signaling of the lysophosphatidylserine receptors GPR34 and GPR174.
Liu G; Li X; Wang Y; Zhang X; Gong W
PLoS Biol; 2023 Dec; 21(12):e3002387. PubMed ID: 38048360
[TBL] [Abstract][Full Text] [Related]
12. Membrane Phospholipid Analogues as Molecular Rulers to Probe the Position of the Hydrophobic Contact Point of Lysophospholipid Ligands on the Surface of G-Protein-Coupled Receptor during Membrane Approach.
Sayama M; Uwamizu A; Otani Y; Inoue A; Aoki J; Sekijima M; Ohwada T
Biochemistry; 2020 Mar; 59(11):1173-1201. PubMed ID: 32124599
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS
Shinjo Y; Makide K; Satoh K; Fukami F; Inoue A; Kano K; Otani Y; Ohwada T; Aoki J
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):332-338. PubMed ID: 29017923
[TBL] [Abstract][Full Text] [Related]
14. Exploration of LPS
Chen L; Uwamizu A; Sayama M; Kano K; Otani Y; Kondo S; Inoue A; Aoki J; Ohwada T
Eur J Med Chem; 2023 Apr; 252():115271. PubMed ID: 36965226
[TBL] [Abstract][Full Text] [Related]
15. Probing the Hydrophobic Binding Pocket of G-Protein-Coupled Lysophosphatidylserine Receptor GPR34/LPS
Sayama M; Inoue A; Nakamura S; Jung S; Ikubo M; Otani Y; Uwamizu A; Kishi T; Makide K; Aoki J; Hirokawa T; Ohwada T
J Med Chem; 2017 Jul; 60(14):6384-6399. PubMed ID: 28715213
[TBL] [Abstract][Full Text] [Related]
16. Identification of a lysophosphatidylserine receptor on mast cells.
Sugo T; Tachimoto H; Chikatsu T; Murakami Y; Kikukawa Y; Sato S; Kikuchi K; Nagi T; Harada M; Ogi K; Ebisawa M; Mori M
Biochem Biophys Res Commun; 2006 Mar; 341(4):1078-87. PubMed ID: 16460680
[TBL] [Abstract][Full Text] [Related]
17. Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid.
Omi J; Kano K; Aoki J
Cell Biochem Biophys; 2021 Sep; 79(3):497-508. PubMed ID: 34129148
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
Im DS
Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
[TBL] [Abstract][Full Text] [Related]
19. The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function.
Barnes MJ; Li CM; Xu Y; An J; Huang Y; Cyster JG
J Exp Med; 2015 Jun; 212(7):1011-20. PubMed ID: 26077720
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylserine stimulates chemotactic migration of colorectal cancer cells through GPR34 and PI3K/Akt pathway.
Iida Y; H Tsuno N; Kishikawa J; Kaneko K; Murono K; Kawai K; Ikeda T; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Yatomi Y; Watanabe T
Anticancer Res; 2014 Oct; 34(10):5465-72. PubMed ID: 25275042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
